SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TCM - Quaterly Results

27 May 2026 Evaluate
The sales is pegged at Rs. 39.70 millions for the March 2026 quarter. The mentioned figure indicates a decline of about -45.46% as against Rs. 72.79 millions during the year-ago period.The Net Loss for the quarter ended March 2026 is Rs. -12.71 millions as compared to Net Profit of Rs. 43.06 millions of corresponding quarter ended March 2025Operating profit Margin for the quarter ended March 2026 slipped to -6.61% as compared to 46.68% of corresponding quarter ended March 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 39.70 72.79 -45.46 172.35 247.27 -30.30 172.35 247.27 -30.30
Other Income 2.90 43.76 -93.37 12.98 47.81 -72.85 12.98 47.81 -72.85
PBIDT -6.61 46.68 -114.16 -13.91 38.65 -135.99 -13.91 38.65 -135.99
Interest 4.93 3.07 60.59 19.20 5.90 225.42 19.20 5.90 225.42
PBDT -11.54 43.61 -126.46 -33.11 32.75 -201.10 -33.11 32.75 -201.10
Depreciation 1.17 0.89 31.46 3.53 1.60 120.62 3.53 1.60 120.62
PBT -12.71 42.72 -129.75 -36.64 31.15 -217.62 -36.64 31.15 -217.62
TAX 0.00 -0.34 0.00 -0.38 -0.34 11.76 -0.38 -0.34 11.76
Deferred Tax 0.00 -0.34 0.00 0.00 -0.34 0.00 0.00 -0.34 0.00
PAT -12.71 43.06 -129.52 -36.26 31.49 -215.15 -36.26 31.49 -215.15
Equity 74.78 74.78 0.00 74.78 74.78 0.00 74.78 74.78 0.00
PBIDTM(%) -16.65 64.13 -125.96 -8.07 15.63 -151.63 -8.07 15.63 -151.63

TCM Share Price

45.50 -2.75 (-5.70%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2732.95
BASF India 3291.00
Tata Chemicals 719.95
Pidilite Inds. 1503.95
Deepak Nitrite 1666.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×